J. Michael McGinnis, M.D., M.P.P., Harvey V. Fineberg, M.D., Ph.D., and Victor J. Dzau, M.D.
doi : 10.1056/NEJMp2103872
N Engl J Med 2021; 385:1-5
Richard Platt, M.D., Gregory E. Simon, M.D., and Adrian F. Hernandez, M.D.
doi : 10.1056/NEJMp2101700
N Engl J Med 2021; 385:5-7
Katrina Armstrong, M.D., M.S.C.E.
doi : 10.1056/NEJMp2100086
N Engl J Med 2021; 385:7-9
Kevin G. Volpp, M.D., Ph.D., and Carolyn C. Cannuscio, Sc.D.
doi : 10.1056/NEJMp2107719
N Engl J Med 2021; 385:e1
Annie K. Sparrow, M.D., M.P.H., Lisa M. Brosseau, Sc.D., Robert J. Harrison, M.D., M.P.H., and Michael T. Osterholm, Ph.D., M.P.H.
doi : 10.1056/NEJMp2108567
N Engl J Med 2021; 385:e2
Andrew J. McArdle, M.B., B.Chir., Ortensia Vito, M.Sc., Harsita Patel, M.B., B.S., Eleanor G. Seaby, B.M., B.S., Priyen Shah, M.B., B.S., Clare Wilson, M.B., B.Chir., Claire Broderick, M.B., B.S., Ruud Nijman, M.D., Ph.D., Adriana H. Tremoulet, M.D., Daniel Munblit, M.D., Ph.D., Rolando Ulloa-Gutierrez, M.D., Michael J. Carter, B.M., B.Ch., D.Phil., et al., for the BATS Consortium*
doi : 10.1056/NEJMoa2102968
N Engl J Med 2021; 385:11-22
Evidence is urgently needed to support treatment decisions for children with multisystem inflammatory syndrome (MIS-C) associated with severe acute respiratory syndrome coronavirus 2.
Mary Beth F. Son, M.D., Nancy Murray, M.Sc., Kevin Friedman, M.D., Cameron C. Young, Margaret M. Newhams, M.P.H., Leora R. Feldstein, Ph.D., Laura L. Loftis, M.D., Keiko M. Tarquinio, M.D., Aalok R. Singh, M.D., Sabrina M. Heidemann, M.D., Vijaya L. Soma, M.D., Becky J. Riggs, M.D., et al., for the Overcoming COVID-19 Investigators*
doi : 10.1056/NEJMoa2102605
N Engl J Med 2021; 385:23-34
The assessment of real-world effectiveness of immunomodulatory medications for multisystem inflammatory syndrome in children (MIS-C) may guide therapy.
Detlef Schuppan, M.D., Ph.D., Markku M?ki, M.D., Ph.D., Knut E.A. Lundin, M.D., Ph.D., Jorma Isola, M.D., Ph.D., Tina Friesing-Sosnik, M.D., Juha Taavela, M.D., Ph.D., Alina Popp, M.D., Ph.D., Jari Koskenpato, M.D., Jost Langhorst, M.D., ?istein Hovde, M.D., Ph.D., Marja-Leena L?hdeaho, M.D., Ph.D., Stefano Fusco, M.D., et al., for the CEC-3 Trial Group*
doi : 10.1056/NEJMoa2032441
N Engl J Med 2021; 385:35-45
In celiac disease, small intestinal transglutaminase 2 causes deamidation of glutamine residues in gluten peptides, which enhances stimulation of T cells and leads to mucosal injury. Inhibition of transglutaminase 2 is a potential treatment for celiac disease.
Efstathios Kastritis, M.D., Giovanni Palladini, M.D., Monique C. Minnema, M.D., Ashutosh D. Wechalekar, M.D., Arnaud Jaccard, M.D., Hans C. Lee, M.D., Vaishali Sanchorawala, M.D., Simon Gibbs, M.B., B.S., Peter Mollee, M.B., B.S., Christopher P. Venner, M.D., Jin Lu, M.D., Stefan Sch?nland, M.D., et al., for the ANDROMEDA Trial Investigators*
doi : 10.1056/NEJMoa2028631
N Engl J Med 2021; 385:46-58
Systemic immunoglobulin light-chain (AL) amyloidosis is characterized by deposition of amyloid fibrils of light chains produced by clonal CD38+ plasma cells. Daratumumab, a human CD38-targeting antibody, may improve outcomes for this disease.
Allan H. Ropper, M.D., and Joshua P. Klein, M.D., Ph.D.
doi : 10.1056/NEJMra2106545
N Engl J Med 2021; 385:59-64
Robert Humphries, M.B., B.Chir., and Malcolm Cameron, M.B., B.S., B.D.S.
doi : 10.1056/NEJMicm2028154
N Engl J Med 2021; 385:65
Daniel L. Varela, M.D., and Tara L. Jones, M.D., Pharm.D.
doi : 10.1056/NEJMicm2029179
N Engl J Med 2021; 385:e3
Lauren Pischel, M.D., Arnar Geirsson, M.D., John Magaldi, M.D., Richard A. Martinello, M.D., and Alfred I. Lee, M.D., Ph.D.
doi : 10.1056/NEJMcps2034802
N Engl J Med 2021; 385:66-72
Roberta L. DeBiasi, M.D.
doi : 10.1056/NEJMe2108276
N Engl J Med 2021; 385:74-75
Bana Jabri, M.D., Ph.D.
doi : 10.1056/NEJMe2107502
N Engl J Med 2021; 385:76-77
Eric J. Rubin, M.D., Ph.D., Lindsey R. Baden, M.D., and Stephen Morrissey, Ph.D.
doi : 10.1056/NEJMe2110939
N Engl J Med 2021; 385:e13
Patrick Turley, Ph.D., Michelle N. Meyer, Ph.D., J.D., Nancy Wang, S.B., David Cesarini, Ph.D., Evelynn Hammonds, Ph.D., Alicia R. Martin, Ph.D., Benjamin M. Neale, Ph.D., Heidi L. Rehm, Ph.D., Louise Wilkins-Haug, M.D., Ph.D., Daniel J. Benjamin, Ph.D., Steven Hyman, M.D., David Laibson, Ph.D., et al.
doi : 10.1056/NEJMsr2105065
N Engl J Med 2021; 385:78-86
Joseph F. Costello, Ph.D., and Susan J. Fisher, Ph.D.
doi : 10.1056/NEJMcibr2106321
N Engl J Med 2021; 385:87-89
doi : 10.1056/NEJMc2103825
N Engl J Med 2021; 385:90-92
doi : 10.1056/NEJMc2107209
N Engl J Med 2021; 385:92-93
doi : 10.1056/NEJMc2106975
N Engl J Med 2021; 385:93-94
doi : 10.1056/NEJMc2106143
N Engl J Med 2021; 385:94-96
doi : 10.1056/NEJMc2106918
N Engl J Med 2021; 385:e4
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟